BRILLANTI, STEFANO
BRILLANTI, STEFANO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy
2021 Frazzoni L.; Sikandar U.; Mazzella G.; Fuccio L.; Bazzoli F.; Brillanti S.; Azzaroli F.
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C.
2012 Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M.; Brillanti S.; Andreone P.
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS
2016 Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G; Brillanti, S
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice
2016 Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglioli, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G.; Andreone, P.
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
2018 Buonfiglioli, Federica; Brillanti, Stefano
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
2016 Conti, Fabio; Buonfiglioli, Federica; Scuteri, Alessandra; Crespi, Cristina; Bolondi, Luigi; Caraceni, Paolo; Foschi, Francesco Giuseppe; Lenzi, Marco; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Brillanti, Stefano
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study.
2005 Mangia A.; Cimino L.; Persico M.; Demelia L.; Rumi M.; Spinzi G.; Fatuzzo F.; Levrero M.; Frugiuele P.L.; Fornaciari G.; De Stefano G.; Venturoni L.; Roda E.; Brillanti S.
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project
2022 Borghi C, Ciancio A, Gentile I, Perrone Filardi P, Pasqualetti P, Brillanti S.
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT
2019 Marasco, G; Dajti, E; Ravaioli, F; Colecchia, A; Reggiani, MLB; Colli, A; Alemanni, LV; Tame, MR; Andreone, P; Brillanti, S; Azzaroli, F; Mazzella, G; Festi, D
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals
2018 Ravaioli, Federico; Conti, Fabio; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Buonfiglioli, Federica; Serio, Ilaria; Verucchi, Gabriella ; Bacchi Reggiani, Maria Letizia; Colli, Agostino; Marasco, Giovanni; Colecchia, Antonio; Festi, Davide*
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study
2005 Lodato F.; Azzaroli F.; Brillanti S.; Colecchia A.; Tame M.R.; Montagnani M.; Muratori R.; Giovanelli S.; Feletti V.; Bacchi Reggiani M.L.; Roda E.; Mazzella G.
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis
2018 Renzulli, Matteo; Buonfiglioli, Federica; Conti, Fabio; Brocchi, Stefano; Serio, Ilaria; Foschi, Francesco Giuseppe; Caraceni, Paolo; Mazzella, Giuseppe; Verucchi, Gabriella; Golfieri, Rita; Andreone, Pietro; Brillanti, Stefano
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy.
2016 Renzulli, Matteo; Buonfiglioli, Federica; Brocchi, Stefano; Conti, Fabio; Serio, Ilaria; Caraceni, Paolo; Foschi, Francesco G; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Golfieri, Rita; Brillanti, Stefano.
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals
2018 Casadei Gardini, Andrea; Conti, Fabio; Foschi, Francesco Giuseppe; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Ravaioli, Federico; Buonfiglioli, Federica; Bolondi, Luigi; Crespi, Cristina; Lenzi, Marco; Muratori, Paolo; Verucchi, Gabriella; Badia, Lorenzo; Bernardi, Mauro; Caraceni, Paolo; Morelli, Maria Cristina; Berardi, Sonia
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals
2019 Casadei Gardini, Andrea; Foschi, Francesco Giuseppe; Conti, Fabio; Petracci, Elisabetta; Vukotic, Ranka; Marisi, Giorgia; Buonfiglioli, Federica; Vitale, Giovanni; Ravaioli, Federico; Gitto, Stefano; Verucchi, Gabriella; Lenzi, Marco; Bolondi, Luigi; Mazzella, Giuseppe; Brillanti, Stefano; Andreone, Pietro*
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients
2019 Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti, S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F.
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo.
2007 Brillanti S.
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients
2017 Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; Verucchi, G.; Bacchi Reggiani, M.L.; Marasco, G.; Colecchia, A.; Festi, D.
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues.
2013 Stefano Brillanti; Liboria Laterza; Paolo Cecinato; Franco Bazzoli
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression?
2002 Vivarelli M.; Bellusci R.; Cucchetti A.; Cavrini G.; De Ruvo N.; Aden A.A.; La Barba G.; Brillanti S.; Cavallari A
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy | Frazzoni L.; Sikandar U.; Mazzella G.; Fuccio L.; Bazzoli F.; Brillanti S.; Azzaroli F. | 2021-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. | Loggi E.; Scuteri A.; Panno A.M.; Grandini E.; Cursaro C.; Margotti M.; Foglianti G.; Bernardi M....; Brillanti S.; Andreone P. | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS | Buonfiglioli, F; Conti, F; Andreone, P; Crespi, C; Foschi, Fg; Lenzi, M; Mazzella, G; Verucchi, G...; Brillanti, S | 2016-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice | Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglio...li, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G.; Andreone, P. | 2016-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum | Buonfiglioli, Federica; Brillanti, Stefano | 2018-01-01 | HEPATOMA RESEARCH | - | 1.01 Articolo in rivista | - |
| Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals | Conti, Fabio; Buonfiglioli, Federica; Scuteri, Alessandra; Crespi, Cristina; Bolondi, Luigi; Cara...ceni, Paolo; Foschi, Francesco Giuseppe; Lenzi, Marco; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Brillanti, Stefano | 2016-01-01 | JOURNAL OF HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. | Mangia A.; Cimino L.; Persico M.; Demelia L.; Rumi M.; Spinzi G.; Fatuzzo F.; Levrero M.; Frugiue...le P.L.; Fornaciari G.; De Stefano G.; Venturoni L.; Roda E.; Brillanti S. | 2005-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project | Borghi C, Ciancio A, Gentile I, Perrone Filardi P, Pasqualetti P, Brillanti S. | 2022-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | Borghi C_Evaluation of drug interactions_J Clin Med.pdf; jcm-11-06946-s001.zip |
| HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT | Marasco, G; Dajti, E; Ravaioli, F; Colecchia, A; Reggiani, MLB; Colli, A; Alemanni, LV; Tame, MR;... Andreone, P; Brillanti, S; Azzaroli, F; Mazzella, G; Festi, D | 2019-01-01 | GUT | BMJ PUBLISHING GROUP | 4.01 Contributo in Atti di convegno | - |
| Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals |
Ravaioli, Federico; Conti, Fabio; Brillanti, Stefano; Andreone, Pietro; Mazzella, Giuseppe; Buonf...iglioli, Federica; Serio, Ilaria; Verucchi, Gabriella ; Bacchi Reggiani, Maria Letizia; Colli, Agostino; Marasco, Giovanni; Colecchia, Antonio; Festi, Davide* |
2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study | Lodato F.; Azzaroli F.; Brillanti S.; Colecchia A.; Tame M.R.; Montagnani M.; Muratori R.; Giovan...elli S.; Feletti V.; Bacchi Reggiani M.L.; Roda E.; Mazzella G. | 2005-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis | Renzulli, Matteo; Buonfiglioli, Federica; Conti, Fabio; Brocchi, Stefano; Serio, Ilaria; Foschi, ...Francesco Giuseppe; Caraceni, Paolo; Mazzella, Giuseppe; Verucchi, Gabriella; Golfieri, Rita; Andreone, Pietro; Brillanti, Stefano | 2018-01-01 | EUROPEAN RADIOLOGY | - | 1.01 Articolo in rivista | - |
| Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. | Renzulli, Matteo; Buonfiglioli, Federica; Brocchi, Stefano; Conti, Fabio; Serio, Ilaria; Caraceni..., Paolo; Foschi, Francesco G; Mazzella, Giuseppe; Verucchi, Gabriella; Andreone, Pietro; Golfieri, Rita; Brillanti, Stefano. | 2016-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals | Casadei Gardini, Andrea; Conti, Fabio; Foschi, Francesco Giuseppe; Brillanti, Stefano; Andreone, ...Pietro; Mazzella, Giuseppe; Ravaioli, Federico; Buonfiglioli, Federica; Bolondi, Luigi; Crespi, Cristina; Lenzi, Marco; Muratori, Paolo; Verucchi, Gabriella; Badia, Lorenzo; Bernardi, Mauro; Caraceni, Paolo; Morelli, Maria Cristina; Berardi, Sonia | 2018-01-01 | GASTROENTEROLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals | Casadei Gardini, Andrea; Foschi, Francesco Giuseppe; Conti, Fabio; Petracci, Elisabetta; Vukotic,... Ranka; Marisi, Giorgia; Buonfiglioli, Federica; Vitale, Giovanni; Ravaioli, Federico; Gitto, Stefano; Verucchi, Gabriella; Lenzi, Marco; Bolondi, Luigi; Mazzella, Giuseppe; Brillanti, Stefano; Andreone, Pietro* | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients | Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti,... S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F. | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| La ribavirina nell'epatite cronica C: storia e segreti di un grande successo. | Brillanti S. | 2007-01-01 | CURRENT OPINION IN GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients | Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; ...Verucchi, G.; Bacchi Reggiani, M.L.; Marasco, G.; Colecchia, A.; Festi, D. | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues. | Stefano Brillanti; Liboria Laterza; Paolo Cecinato; Franco Bazzoli | 2013-01-01 | HEPATOLOGY INTERNATIONAL | - | 1.06 Abstract in rivista | - |
| Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? | Vivarelli M.; Bellusci R.; Cucchetti A.; Cavrini G.; De Ruvo N.; Aden A.A.; La Barba G.; Brillant...i S.; Cavallari A | 2002-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | - |